Special Issue "Cannabinoids"
A special issue of Pharmaceuticals (ISSN 1424-8247).
Deadline for manuscript submissions: closed (30 June 2010).
Interests: cannabinoid; artery; vasorelaxation; vascular function; adipose tissue; obesity; metabolic syndrome; gut permeability; nuclear receptor; PPARs
Interests: pharmacology and clinical studies of natural and synthetic drugs, mainly cannabinoids and opioids; development of pulmonal applications forms; heroin maintenance programs; development and validation of chromatographic-spectroscopic methods for pharmacological, toxicological and pharmaceutical applications; cannabis profiling (chemical fingerprinting); monitoring of drugs in body fluids; pharmacokinetic profiling and metabolism of drugs and drugs of abuse; ethnopharmacognosy and -pharmacology of medicinal plants
We invite authors to submit papers to Pharmaceuticals in the exciting field of Cannabinoid research. This special issue is to include original articles on basic or clinical reserach on the endocannabinoid system (including enocannabinoids and the enzymes involved in their synthesis and degradation), phytocannabinoid (such as THC, CBD, THCV) or cannabis preparations (such as Sativex) in any reserach area, but particularly investigations looking at novel compounds or novel sites of action. We also welcome review articles on complex and controversial areas in cannabinoid pharmacology.
Prof. Dr. Rudolf Brenneisen
Dr. Saoirse O'Sullivan
- cannabis-based medicines
- cannabinoid receptors
- nuclear receptors
- novel receptor sites of action
- orphan g-protein coupled receptors
- basic research
- clinical trials
- cardiovascular system
- respiratory system
- adipose tissue
- bone growth
- central nervous sytem
- Cannabinoids as Medicines in Pharmaceuticals (4 articles)
- Cannabidiol: Advances in Therapeutic Applications and Future Perspectives in Pharmaceuticals (5 articles)